Fig. 7 | Scientific Reports

Fig. 7

From: The molecular subtype based on cell cycle-related gene signature predicts the prognosis and chemotherapy and immunotherapy response in gastric cancer

Fig. 7

The validation of PDEGs score and corresponding risk model in GSE13861 and GSE26901 cohorts. (A) The survival plot of high score and low score groups in GSE13861 cohort (log-rank tests, P = 0.013). (B) The survival plot of high score and low score groups in GSE26901 cohort (log-rank tests, P = 0.88). (C) Alluvial diagram of the subtype distributions in groups with different PDEGs score and survival outcomes in GSE1386. (D) The survival plot of high score and low score groups in chemotherapy subgroup of GSE13861 cohort (log-rank tests, P = 0.093). (E) Age, PDEGs score and TNM stage were independent factors of OS in validation set (GSE13861). (F, G) Time-dependent ROC curves (F) and time-dependent AUC curve (G) evaluating the performance of score-group-based model to predicting prognosis of patients in validation set (GSE13861).

Back to article page